Martin Brenner is the founder of iBio. iBio has raised $50M in total funding. Latest round: Growth. Based in San Diego, California.
Martin Brenner is the CEO of iBio, a publicly traded biotech company that develops therapies for obesity and cardiometabolic disorders. Prior to his role at iBio, Brenner held leadership positions at several major pharmaceutical companies including Eli Lilly, Pfizer, AstraZeneca, and Merck. iBio recently raised $50 million through a public offering.
Full founder directory · Investor directory · Company funding database · Fundraising library